Patent Assignment
Reel/Frame 040362/0884
Security Interest
Recorded: 2016-11-17
Pages: 11
Assignor
TOLERO PHARMACEUTICALS, INC.
Executed: 2016-11-02
Assignee
SUMITOMO DAINIPPON PHARMA CO., LTD.
6-8 DOSHOMACHI 2-CHOME, CHUO-KU, OSAKA, 541-0045, JAPAN
Covered Properties
(38)
Imidazo[1,2-Beta]Pyridazine and Pyrazolo[1,5-Alpha]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Pyrimidine-2,4-Diamine Derivatives and Their Use as JAK2 Kinase Inhibitors
Application:
12/040,002 →
Publication:
US 2008/0214558
Axl Kinase Inhibitors
Methods and Compounds for Treating Pim-1 Kinase-Expressing Cancer Cells
Application:
12/785,322 →
Publication:
US 2010/0227861
Axl Kinase Inhibitors
Application:
13/183,197 →
Publication:
US 2011/0269772
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES AS PROTEIN KINASE INHIBITORS
Multiple Kinase Pathway Inhibitors
PKM2 Modulators and Methods for Their Use
JAK2 and ALK2 Inhibitors and Methods for Their Use
Predicting Response to Alvocidib by Mitochondrial Profiling
Alvocidib Prodrugs Having Increased Bioavailability
PKM2 Modulators and Methods for Their Use
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Multiple Kinase Pathway Inhibitors
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
Application:
60/864,566 →
Pyrimidine-2,4-Diamine Derivatives and Their Use as JAK2 Kinase Inhibitors
Application:
60/892,385 →
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
Application:
60/892,523 →
Pyrimidine-2,4-Diamine Derivatives and Their Use as JAK2 Kinase Inhibitors
Application:
60/911,776 →
Axl Kinase Inhibitors
Application:
60/911,832 →
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
Application:
60/957,988 →
[1,2,4]Triazolo[4,3-A]Pyridine Derivatives and Their Use as Protein Kinase Inhibitors
Application:
61/510,207 →
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Application:
61/608,028 →
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Application:
61/632,826 →
Imidazo[1,2-B]Pyridazine and Pyrazolo[1,5-a]Pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Application:
61/632,834 →
Publication:
US 2012/0058997
Multiple Kinase Pathway Inhibitors
Application:
61/706,084 →
PKM2 Modulators and Methods for Their Use
Application:
61/714,659 →
Multiple Kinase Pathway Inhibitors
Application:
61/757,331 →
JAK2 and ALK2 Inhibitors and Methods for Their Use
Application:
61/785,460 →
Multiple Kinase Pathway Inhibitors
Application:
61/785,992 →
PKM2 Modulators and Methods for Their Use
Application:
61/875,855 →
Methods to Target Transcriptional Control at Super-Enhancer Regions
Application:
62/077,042 →
Targeting the Pim Kinases in Combination with Btk Inhibition Is Synergistic in Preclinical Models of B-Cell Malignancies
Application:
62/142,354 →
Methods to Target Transcriptional Control at Super-Enhancer Regions
Application:
62/150,110 →
Predicting Response to Alvocidib by Mitochondrial Profiling
Application:
62/150,138 →
Targeting Pim Kinases in Combination with Btk Inhibition
Application:
62/150,695 →
Alvocidib Prodrugs Having Increased Bioavailability
Application:
62/163,188 →
Combination Therapies for Treatment of Cancer
Application:
62/200,499 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 2, 2007
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; LIU, XIAO-HUI
To: SUPERGEN, INC.
Reel/Frame 018954/0792 →
Assignment of Assignor's Interest
Mar 30, 2007
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 019095/0209 →
Assignment of Assignor's Interest
Apr 17, 2007
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 019169/0031 →
Assignment of Assignor's Interest
Apr 25, 2007
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 019211/0413 →
Assignment of Assignor's Interest
Nov 8, 2007
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 020085/0921 →
Assignment of Assignor's Interest
Mar 13, 2008
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD
To: SUPERGEN, INC.
Reel/Frame 020648/0486 →
Assignment of Assignor's Interest
Mar 28, 2008
From: BEARSS, DAVID J.; LIU, XIAO-HUI; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 020721/0348 →
Assignment of Assignor's Interest
May 8, 2008
From: VANKAYALAPATI, HARIPRASAD; LIU, XIAO-HUI; BEARSS, DAVID J.
To: SUPERGEN, INC.
Reel/Frame 020918/0017 →
Assignment of Assignor's Interest
Jul 29, 2008
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; XU, YONG
To: SUPERGEN, INC.
Reel/Frame 021309/0536 →
Assignment of Assignor's Interest
Nov 15, 2011
From: XU, YONG; YUAN, YI; BRENNING, BENJAMIN G.; HO, KOC-KAN
To: SUPERGEN, INC.
Reel/Frame 027230/0779 →
Merger/Name Change
Feb 22, 2012
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS. INC.
Reel/Frame 027747/0334 →
Assignment of Assignor's Interest
Jul 26, 2012
From: ASTEX PHARMACEUTICALS, INC.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 028650/0717 →
Assignment of Assignor's Interest
Aug 12, 2014
From: XU, YONG; BRENNING, BENJAMIN GARY; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 033521/0153 →
Assignment of Assignor's Interest
Aug 10, 2015
From: MOLLARD, ALEXIS; WARNER, STEVEN L.; FLYNN, GARY A.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 036291/0103 →
Assignment of Assignor's Interest
Aug 10, 2015
From: ZENG, QINGPING; FARIS, MARY
To: MANNKIND CORPORATION
Reel/Frame 036291/0088 →
Assignment of Assignor's Interest
Nov 10, 2015
From: HO, KOC-KAN; XU, YONG; SAUNDERS, MICHAEL DAVID; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 037005/0571 →
Assignment of Assignor's Interest
Mar 22, 2016
From: MOLLARD, ALEXIS; WARNER, STEVEN L.; FLYNN, GARY A.; VANKAYALAPATI, HARIPRASAD
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 038068/0314 →
Assignment of Assignor's Interest
Aug 5, 2016
From: SIDDIQUI-JAIN, ADAM; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 039358/0432 →
Assignment of Assignor's Interest
Aug 31, 2016
From: WARNER, STEVEN L.; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 039601/0719 →
Assignment of Assignor's Interest
Dec 19, 2018
From: HO, KOC-KAN; XU, YONG; SAUNDERS, MICHAEL DAVID; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 047959/0693 →
Release of Security Interest
Aug 13, 2019
From: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
To: MANNKIND CORPORATION
Reel/Frame 050044/0138 →
Security Interest
Aug 13, 2019
From: MANNKIND CORPORATION; MANNKIND LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050044/0181 →
Assignment of Assignor's Interest
Apr 27, 2020
From: XU, YONG; BRENNING, BENJAMIN GARY; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 052500/0211 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053181/0114 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0344 →